Arkhypov et al. demonstrated that soluble heat-shock protein 90α (HSP90α) prompts monocytes to become MDSC via TLR4 signaling and PD-L1 expression, potentially offering a target for countering immunosuppression in melanoma and improving immune-based therapies[86]. This evidence concerns the gene CD274 and melanoma.